Govt of India and Japan Sign MoU to Launch Joint Research Initiatives

The Ministry of Science & Technology (DBT & DST), Government of India and RIKEN, Japan’s largest research organisation have signed MoUs for launching joint research programs in the fields of Biology, Life sciences and Material Sciences. (Genome–related research including systems Biology, Computational science including development of Bioinformatics tools, Detection tools for security and other areas of mutual interest)

The Memorandum of Understandings (MoUs) were signed by Prof Noyori, President of RIKEN and Dr T Ramasami, Secretary, Department of Science& Technology (DST) and Dr K VijayRaghavan, Secretary, Department of Bio-Technology (DBT). This will formally launch the RIKEN- DBT&DST Joint Research activities.

The cooperation will facilitate exchange and foster collaborations between Japan and India, in these fields. They extend a long history of collaboration between India and Japan, two powerhouses of Asian research and innovation.

Speaking on the occasion Dr K Vijay Raghwan, Secretary DBT said this MoU will usher in a new era of cooperation in the area of innovations and techniques for the agricultural and pharmacological industries in India.

Dr T Ramasami, Secretary DST hoped recognising the importance of science and technology and the high potential of further cooperation in various areas of research between the DST and RIKEN will further the scope of new inventions.

The Ambassador of Japan to India, Takeshi Yagi said mutual cooperation between the two prominent Asian countries in the fields of Biology, Life sciences and material sciences is an important phenomena and such steps need further strengthening.

"Exciting news! Elets Education is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.